ETFs Kamada Ltd.

KMDA

IL0010941198

Pharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE 06:44:26 2026-08-28 EDT			5-day change	1st Jan Change
2,487.00 ^ILa	+2.43%		+3.20%	+10.04%

08-17	Kamada Lowers Quarterly Dividend to $0.17 a Share; Payable Sept. 17 to Holders of Record Aug. 27	MT
08-17	Kamada Ltd. Declares Cash Dividend, Payable on September 17, 2026	CI

ETFs positioned on Kamada Ltd.

Name	YTD change	Weight	AuM
DIMENSIONAL INTERNATIONAL SMALL CAP ETF - USD	+14.25%	-.--%	5,871 M€
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD	+25.67%	0.04%	1,079 M€
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD	+25.62%	0.04%	78 M€
INVESCO NASDAQ BIOTECHNOLOGY ETF - USD	+24.91%	0.03%	81 M€
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP ETF - USD	+12.09%	0.01%	12,001 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+15.29%	0%	1,674 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+16.27%	0%	12,086 M€
CCM GLOBAL EQUITY ETF - USD	+15.84%	0%	1,199 M€
VANGUARD BALANCED ETF PORTFOLIO - CAD	+8.44%	0%	4,204 M€
AVANTIS INTERNATIONAL EQUITY ETF - USD	+13.97%	0%	18,816 M€

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Employees

462

Sector

Pharmaceuticals

More about the company